| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.3 | 3e-09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 4e-05 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |